 Virus-specific T-lymphocytes (VST) therapy is used for patients who have received hematopoietic stem cell transplantation that has proven to be unsuccessful.It is a treatment that has been effective in preventing and treating viral infections after HSCT.VST therapy uses active donor T-cells that are isolated from alloreactive T-cells which have proven immunity against one or more viruses.